Allogene Therapeutics, Inc. (ALLO)
1.70
+0.06
(+3.66%)
USD |
NASDAQ |
Jan 14, 16:00
1.71
+0.01
(+0.59%)
After-Hours: 20:00
Allogene Therapeutics EPS Diluted (Quarterly): -0.1864 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.133 |
| AIM ImmunoTech, Inc. | -1.567 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.40M |
| Total Expenses (Quarterly) | 41.40M |
| Enterprise Value | 201.51M |
| Earnings Yield | -57.71% |
| Normalized Earnings Yield | -57.27 |